SeaStar Medical Holding Corp (ICU): רווח נקי למניה (EPS TTM)

SeaStar Medical Holding demonstrates strong regulatory expertise in inflammation therapy, although its pre-revenue stage necessitates close monitoring of expenses. The 12-month net income per share snapshot visualizes financial stability, where the value of -3.65 reflects this status. Stable demand for intensive care equipment renders the business non-cyclical, while the utilization of external CDMO lines optimizes R&D processes and minimizes operational risks.
פילוחים אנליטיים ודוחות נתונים של חברת SeaStar Medical Holding Corp (ICU)

This indicator determines the investment reliability of the issuer through the lens of real earnings per share. The metric aggregates annual net income, excluding the impact of share issuances or buybacks. By analyzing the TTM net income per share on the GURU.Markets platform, an investor gains an objective view of profitability trends. Current values for SeaStar Medical Holding (ICU) are constrained by high costs associated with deploying devices in clinics. Future sales scaling should reduce unit costs and activate operating leverage.